New Analyses from Three Trials in Obstructive HCM Support Findings from Previously Published Data on MYQORZO™ (aficamten)SOUTH SAN FRANCISCO, ...
Mitral annular calcification with valve dysfunction remains a challenging syndrome. Operative risk is high, and available transcatheter therapies are limited. This study describes our initial ...
The HighLife Transcatheter Mitral Valve Replacement (TMVR) system achieves a 90% technical success rate and effectively eliminates leakage in 88% of high-risk patients, as a recent study has shown.
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares Russell 3000 ETF (Symbol: IWV) where we have detected an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results